IL33 and amyloidosis: We observed that FAP 0 patients already exhibited a significant increase in levels of IL-33, IL-1β and IL-10 (Fig. 2b, c and e), suggesting that the alterations in immune response might occur before amyloid deposition and symptom appearance.